A Phase II study with FOL-005 for treatment of Alopecia approved by the German Medicines Agency

Follicum AB (“Follicum” or “the Company”) today announces that it has received approval from the German Medicines Agency (BfArM) and the German Ethics Committee to start a Phase IIa clinical study with a topical formulation of FOL-005 on patients with alopecia (hair loss). The trial will comprise about 200 patients who will be treated with FOL-005 or placebo daily for 4 months. …

Hair Today, Gone Tomorrow

HAIR TODAY, GONE TOMORROW — Dealing with Hair Loss, Part 2

Social Acceptance Socially, there are a lot of people who are teased or have been teased for hair loss.  As presented in the first post of this two-part hair loss series, stress can add to hair loss as well as lead to additional personal struggles–social ridicule makes the struggles with hair loss even harder. People are often uneducated or naïve …